The rivalry between Jon Jones and Daniel Cormier is nothing new, but what is new is that Jon Jones tested positive for steroids in trace amounts today. Well, that actually isn’t new, really…
Former UFC light-heavyweight champion Jon Jones had the world at his feet, countless times, but just kept making mistakes. Not so much inside the octagon, where he remains undefeated, but with multiple failed drug tests, felonies and overall poor life choices.
Fans of Jones have been through the mill after multiple failed dope screens for cocaine and steroids. We’ve seen “Bones” dragged through arbitration, USADA (United States Anti Doping Agency) hearings, and yanked from the blockbuster UFC 200 main event.
After knocking out Daniel Cormier during his UFC 214 return, Jones would pop AGAIN, his title was AGAIN stripped and the troubled talent was up against it…AGAIN!
Jon Jones Fails Again And DC Is There To Laugh, USADA Is There To…Well, Who F*cking Knows
So with just 6 days left until UFC 232, another return and chance at another redemption for Jones, surely nothing could go wrong. Well, you know what they say about best-laid plans. Jon Jones, once again, tested positive for Turinabol in ‘trace amount.’ This was the same substance that got Jones stripped of the title after UFC 214.
Only this time, USADA and the California commission is basically giving him a pass. As a result, the UFC moved UFC 232 to Los Angeles on one week’s notice, reportedly without telling other fighters when applying for the change of venue, because the CSAC would license Jones but Nevada wouldn’t.
Daniel Cormier, predictably, was amused:
— Daniel Cormier (@dc_mma) December 24, 2018
“USADA informed the Nevada State Athletic Commission (NSAC) on Thursday that a urine sample collected by USADA from Jon Jones in an out-of-competition test session on December 9, 2018 was reported Thursday by the WADA-accredited laboratory in Salt Lake City to contain an extremely low level of 4-chloro-18-nor-1713-hydroxymethy1,17a-methyl-5a-androst-13-en-3a-ol (M3), a metabolite of dehydrochlormethyltestosterone (DHCMT), or another chlorine-substituted anabolic steroid.
This is the same substance that was detected in Jones’ positive test from July 28, 2017 and for which he received a 15-month sanction from an independent arbitrator under the UFC Anti-Doping Policy. After examining the scientific literature on this substance and the extensive testing history on Jones and consulting with leading scientific experts, USADA has concluded that the extremely low level of DHCMT in Mr. Jones’ December 9, 2018 sample is consistent with residual amounts from his prior exposure for which he was previously sanctioned.
SADA has also concluded that consistent with the prior finding by the independent arbitrator, at these extremely low levels, Jones obtained no performance enhancement from this level. The level reported was at approximately 60 pg/mL and there was no parent drug or other metabolites of the drug in his sample. As a result of these findings, USADA has determined that Mr. Jones is not facing a violation per the UFC Anti-Doping Policy.
As always, sanctioning bodies for each hosting state have jurisdiction over fighter participation and — taking all facts into account— are able to come to their own conclusions under their rules. We are confident after consideration of all the evidence and based on science that the resolution of this result under the UFC Anti-Doping Policy is consistent with USADA’s mandate and in the interests of justice.”